Indoor radon measurement with The Lucas cell technique

Rn-222 is the most important source of natural radiation and is responsible for approximately half of the received dose from all sources. Most of this dose is from inhalation of the Rn-222 progeny, especially in closed atmospheres. A Lucas cell technique, using a portable device, “PRASSI” (SILENA mod. 5S), for Rn-222 measurements inside the Centre for Radiation Protection and Radioecology (ZSR), Hannover University was used. The portable radon monitor PRASSI is suitable for radon gas continuous or grab sampling measurements with the scintillation cell technique. In recognition of the wide periodic variations in concentration, measurements were made daily for extended periods. At the same time, meteorological variables, such as temperature and humidity were observed so that their influence on radon levels could be evaluated. The radon average concentration during the year was about 55.9 Bq/m³ which gives rise to an annual effective dose 2.2 mSv y⁻¹. The radon concentration is within the limits prescribed by the International Commission for Radiation Protection. A detailed analysis of radon distribution with seasonal variation is presented.     

直线加速器十年故障分析总结

目的分析和总直线加速器十多年来的故障。方法根据十多年来的故障维修记录，统计和分析直线加速器各阶故障率及故障特点。结果直线加速器使用早期由于机器不稳定故障率比较高，使用中期及其比较稳定，故障率比较低，使用后期由于零部件老化，故障率比较高。     

安徽省X射线诊断受检者剂量水平调查

目的　了解安徽省X射线诊断受检者体表剂量水平。方法　体表剂量监测按国家标准 ,采用热释光剂量计。结果　胸部摄片受检者的体表剂量最低 ,为 0 .39～ 0 .5 3mGy ,比胸部透视平均体表剂量减少 88.6 6 %。结论　减少或控制透视比例 ,降低受检者群体的体表剂量 ,以减少医疗照射对人体造成的危害。     

周围剂量当量仪的研制

周围剂量当量仪研制是根据国际辐射单位和测量委员会（ＩＣＲＵ）３９号报告推荐的周围剂量当量而设计的一种数字化智能型辐射防护仪。方法采用能量补偿对探测器进行能响校正。结果补偿结果使得探测器在４７～２３０ｋｅＶ与ＩＳＯ推荐的Ｈ＊（１０）／Ｋａ值误差在５％以内。本文重点描述了周围剂量当量仪探测器部分的工艺结构和剂量学性能以及电子学测量部分的主要功能。结论通过实际应用我们初步获得的结论是由于该仪器可直接测量周围剂量当量，稳定性好且具有自动取平均值特点，它可做为实验室校准用测量仪器，又由于该仪器体积小，电池供电，读数面板又有背光功能，它也可以做为现场仪器用于辐射防护实践的现场测量     

Postsynaptic potentiation of end-plate currents in the rat diaphragm during variation in synaptic acetylcholinesterase activity

Leningrad University. (Presented by Academician of the Academy of Medical Sciences of the USSR S. N. Golikov.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 111, No. 5, pp. 458–460, May, 1991.     

In-vitro synthesis of steroid hormones in corpora lutea from normal women and women treated with 300 micrograms norethisterone.

The in-vitro oestradiol (E2) and progesterone (P) production by corpora lutea (CL) obtained at sterilization from 30 untreated women and 43 women treated with norethisterone (NET) 300 micrograms daily was measured. The CL were obtained at different stages of the luteal phase in the untreated women [luteinizing hormone (LH) 0 to +3, n = 7; LH +4 to +7, n = 7; LH +8 to +11, n = 9; LH +12 to menses, n = 7] and on days LH +8 to +11 or cycle days 22 to 26 in the NET-treated women. In the treated women, four types of ovarian reaction were identified. Four women showed ovarian reaction Type A (completely inhibited ovarian activity), 14 women Type B (marked follicular activity, but no luteal function), 12 women Type C (normal follicular activity, followed by insufficient luteal function) and 13 women Type D (apparently normal follicular and luteal activity). The CL were incubated in Eagle's medium with and without stimulation by human chorionic gonadotrophin (HCG) for 2 and 4 h. In the untreated women, P and E2 production increased significantly with both incubation time and stimulation by HCG throughout the luteal phase, except in the late luteal phase (LH +12 to menses) where P increased (P less than 0.01) only after 4 h stimulation by HCG. The maximal production of P was found after 4 h incubation with HCG stimulation of CL tissue in the early-mid luteal phase (LH +4 to +7).(ABSTRACT TRUNCATED AT 250 WORDS)     

放疗中呼吸引起的组织深度波动对吸收剂量的影响

目的研究放疗中呼吸引起的组织深度波动对吸收剂量的影响。方法在不同能量、组织深度波动幅度、呼吸频率及平均测量深度时，分别用研制的能模拟组织深度波动的辐射剂量测量水箱进行测量，以获得“组织深度波动因子”（Fdw）进行比较。结果组织深度波动确实对实际吸收剂量有影响，而且组织深度波动幅度、呼吸频率及射线能量越大，Fdw值越小，即对吸收剂量的影响越大，而Fdw与平均测量深度无关。结论放疗中必须根据患者的呼吸频率、所用射线类型及呼吸引起的组织深度波动幅度用Fdw对肿瘤或组织的实际吸收剂量进行修正，以提高疗效。     

High-dose contrast-enhanced computed tomography (CECT) with iopamidol in the detection of cerebral metastases

Summary Intravenously admistered iodinated contrast media have been demostrated, since early experience with computed tomography of the brain, to improve clinical value of the procedure for detecting intracranial lesions. There is no universal agreement about the amount and the method of administration of the contrast medium. Many authors maintain that the use of large doses gives better results for the diagnosis of tumors and metastases. The purpose of this paper is to evaluate the tolerance of iopamidol administered by rapid intravenous infusion in a large number of patients undergoing contrast enhanced computed tomography to detect brain metastases. The authors examined 969 consecutive adult patients suffering from lung cancer, brain metastases have been detected in 17% of cases. Adverse reactions to contrast media occurred in 3 patients. Non ionic contrast media are recommended in this diagnostic procedure.     

新疆核试验场周围土壤中90Sr137Cs水平

用放射化学分析方法,对新疆核试验场周围10个调查区和远离核试验场位于上风向的5个对照区采取的土壤样品进行了⁹⁰Sr、¹³⁷Cs分析测定。核试验场周围调查区土壤中⁹⁰Sr累积平均沉降量为1.5×10³Bqm^-2,¹³⁷Cs为4.9×10³Bqm^-2;对照区⁹⁰Sr累积平均沉降量为1.3×10³Bqm^-2,¹³⁷Cs为3.9×10³Bqm^-2。调查区和对照区表层土壤中州⁹⁰Sr,¹³⁷Cs放射性平均水平无显著性差异。通过估算得出了调查区⁹⁰Sr、¹³⁷Cs对居民产生约定有效剂量当量分别为78.3μSv(集体剂量当量负担为23.9人·sv)和270μSv(集体剂量当量负担为82.3人·sv),对照区分别为70.5μSv,(集体剂量当量负担为14.1人·sv)和220μSv(集体剂量当量负担为14.1人·sv)。两个地区居民受到来自核试验产生的⁹⁰Sr和¹³⁷Cs给予人体的内照射剂量当量负担基本上是一样的。可认为⁹⁰Sr、¹³⁷Cs对新疆核试验场周围没有造成严重的局部污染。对居民的身体健康不致于产生不良影响。     

Appropriate Replacement Dose of Thyroxine in Primary Hypothyroidism

ABSTRACT An ultrasensitive thyrotropin (TSH) assay was used to determine how many of 65 patients with primary hypothyroidism on thyroxine (T₄) replacement therapy had suppressed serum TSH. In 13 patients (20%) TSH levels ≤0.1 mlU/l were found, indicating an overdose of thyroxine. After correction of the dose, 48 patients had normal TSH values. Their mean dose of thyroxine was 119 μg/24 hours, and the appropriate replacement dose tended to decline with advancing age. The serum level of thyroid hormones during replacement therapy with thyroxine very imperfectly reflected serum TSH values. It is concluded that overdose of thyroxine is common when suppressed serum TSH is used as an end point. Biochemical follow-up of replacement therapy with thyroxine in primary hypothyroidism therefore requires the use of an ultrasensitive TSH assay in order to detect such suppression. Serum levels of thyroxine or triiodothyronine (T₃) during thyroxine therapy are poor indicators of pituitary TSH secretion and are therefore not useful as parameters of adequate thyroxine dosage.